Adverse events during immunotherapy in Slovenian patients with metastatic melanoma reveal a positive correlation with better treatment outcomes Cover

.blurhash-client-img { display: none !important; }

Adverse events during immunotherapy in Slovenian patients with metastatic melanoma reveal a positive correlation with better treatment outcomes

Radiology and Oncology

Volume 55 (2021): Issue 3 (September 2021)

By: Tanja Mesti, Vid Ceplak Mencin, Biljana Mileva Boshkoska and Janja Ocvirk

Open Access

|May 2021

Authors

Tanja Mesti

Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Vid Ceplak Mencin

Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Biljana Mileva Boshkoska

Faculty of information studies in Novo mesto, Novo mesto, Slovenia

Department for Knowledge Technologies, Institute Jožef Stefan, Ljubljana, Slovenia

Janja Ocvirk

jocvirk@onko-i.si

Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

DOI: https://doi.org/10.2478/raon-2021-0019 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 354 - 361

Submitted on: Nov 24, 2020

|

Accepted on: Mar 16, 2021

|

Published on: May 4, 2021

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

immune related adverse events,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2021 Tanja Mesti, Vid Ceplak Mencin, Biljana Mileva Boshkoska, Janja Ocvirk, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 55 (2021): Issue 3 (September 2021)Next article